IMPACT-AML

EU collaborative STREAM for leukemia patients. IMPACT-AML builds a pioneering research framework for Relapse or Refractory Acute Myeloid Leukemia, unifying patients, clinicians, and researchers across Europe and beyond. At its core, STREAM enables real-world evidence integration and supports pragmatic clinical trials, laying the foundation for future patient-centric treatments and advancing collaborative innovation in AML care.